The U.S. Food and Drug Administration on Wednesday authorized storage of Pfizer Inc (PFE.N) and German partner BioNTech SE’s (22UAy.DE) COVID-19 vaccine at standard freezer temperatures for up to one month, in an effort to make the vaccine more widely available.
This content was originally published here.